I think the HY report reminded everyone of the cash rate burn.. some $4.2M for the 6 months with a net loss for the 6 months of $2.4M .
The biotech industry is a slow moving beast and fairly expensive to run, many investors hoping for a quick return will , imo , be likely to leave.
This company is one to hold on to , with a CR of $15M at 11c , they are funded for the foreseeable future.
I still think the company will not reach it's full potential for awhile yet.
The impatient will move on.
Ann: Half Yearly Report and Accounts, page-26
-
- There are more pages in this discussion • 110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
-0.005(1.47%) |
Mkt cap ! $615.4M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 33.5¢ | $165.1K | 486.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 296779 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 40283 | 2 |
View Market Depth
| Last trade - 10.05am 07/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |